Login / Signup

Real-life anti-vascular endothelial growth factor treatment for age-related macular degeneration and diabetic macular edema in an Italian tertiary referral hospital.

Maurizio Battaglia ParodiFrancesco RomanoAlessandro ArrigoRaffaele SacchiGianluca ScanziCamilla FerriFrancesco Bandello
Published in: European journal of ophthalmology (2019)
Our study described the 2-year real-life outcome of anti-vascular endothelial growth factor treatment of diabetic macular edema and age-related macular degeneration.
Keyphrases
  • vascular endothelial growth factor
  • age related macular degeneration
  • endothelial cells
  • primary care
  • emergency department
  • adverse drug
  • smoking cessation